Long-Term  	Long-Term  	 JJ	B-NP
Effects  	Effects  	 NNPS	I-NP
of  	of  	 IN	I-NP
Renal  	Renal  	 NNP	I-NP
Sympathetic  	Sympathetic  	 NNP	I-NP
Denervation  	Denervation  	 NNP	I-NP
on  	on  	 IN	O
Hypertensive  	Hypertensive  	 NNP	B-NP
Patients  	Patients  	 NNPS	I-NP
With  	With  	 IN	O
Mild  	Mild  	 NNP	O
to  	to  	 TO	O
Moderate  	Moderate  	 NNP	O
Chronic  	Chronic  	 NNP	B-NP
Kidney  	Kidney  	 NNP	I-NP
Disease  	Disease  	 NNP	I-NP
Thirty  	Thirty  	 NNP	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
underwent  	underwent  	 VBD	O
percutaneous  	percutaneous  	 JJ	B-NP
renal  	renal  	 JJ	I-NP
denervation 	denervation 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
performed  	performed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
operator  	operator  	 NN	O
following  	following  	 VBG	O
the  	the  	 DT	O
standard  	standard  	 JJ	O
technique 	technique 	 NN	O
,  	,  	 ,	O
were  	were  	 VBD	O
enrolled  	enrolled  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
with  	with  	 IN	O
chronic  	chronic  	 JJ	B-NP
kidney  	kidney  	 NN	I-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
CKD 	CKD 	 NNP	B-NP
)  	)  	 -RRB-	O
stage  	stage  	 NN	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
n=19 	n=19 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
3  	3  	 CD	O
( 	( 	 -LRB-	O
n=6 	n=6 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
4  	4  	 CD	O
( 	( 	 -LRB-	O
n=5 	n=5 	 NNP	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
included 	included 	 VBN	O
.  	.  	 .	O
Data  	Data  	 NNP	O
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
at  	at  	 IN	O
baseline  	baseline  	 NN	B-NP
and  	and  	 CC	O
at  	at  	 IN	O
monthly  	monthly  	 JJ	O
intervals  	intervals  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
6  	6  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
At  	At  	 IN	O
7  	7  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
follow-up  	follow-up  	 JJ	B-NP
data  	data  	 NNS	I-NP
were  	were  	 VBD	O
collected  	collected  	 VBN	O
bimonthly  	bimonthly  	 VBN	O
until  	until  	 IN	O
month  	month  	 NN	O
12 	12 	 CD	O
,  	,  	 ,	O
after  	after  	 IN	O
which  	which  	 WDT	O
data  	data  	 NNS	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
quarterly  	quarterly  	 JJ	O
basis 	basis 	 NN	O
.  	.  	 .	O
Baseline  	Baseline  	 JJ	B-NP
blood  	blood  	 NN	I-NP
pressure  	pressure  	 NN	I-NP
values  	values  	 NNS	I-NP
( 	( 	 -LRB-	O
mean±standard  	mean±standard  	 NNP	B-NP
deviation 	deviation 	 NN	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
185±18 	185±18 	 CD	O
/ 	/ 	 CD	O
107±13  	107±13  	 CD	O
mm  	mm  	 CD	B-NP
Hg  	Hg  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
office  	office  	 NN	O
and  	and  	 CC	O
152±17 	152±17 	 CD	O
/ 	/ 	 CD	O
93±11  	93±11  	 CD	O
mm  	mm  	 CD	B-NP
Hg  	Hg  	 NNS	I-NP
through  	through  	 IN	O
24-hour  	24-hour  	 JJ	O
ambulatory  	ambulatory  	 JJ	B-NP
blood  	blood  	 NN	I-NP
pressure  	pressure  	 NN	I-NP
monitoring  	monitoring  	 NN	I-NP
( 	( 	 -LRB-	O
ABPM 	ABPM 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Three  	Three  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stage  	stage  	 NN	O
4  	4  	 CD	O
CKD  	CKD  	 NNP	B-NP
required  	required  	 VBD	O
chronic  	chronic  	 JJ	B-NP
renal  	renal  	 JJ	I-NP
replacement  	replacement  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
( 	( 	 -LRB-	O
one  	one  	 CD	O
at  	at  	 IN	O
the  	the  	 DT	O
13-month  	13-month  	 NNP	O
follow-up  	follow-up  	 NNP	O
and  	and  	 CC	O
two  	two  	 CD	O
at  	at  	 IN	O
the  	the  	 DT	O
14-month  	14-month  	 JJ	O
follow-up 	follow-up 	 NN	O
)  	)  	 -RRB-	O
after  	after  	 IN	O
episodes  	episodes  	 NNS	O
of  	of  	 IN	O
acute  	acute  	 JJ	O
renal  	renal  	 JJ	B-NP
injury 	injury 	 NN	I-NP
;  	;  	 :	O
their  	their  	 PRP$	O
follow-up  	follow-up  	 NN	O
was  	was  	 VBD	O
subsequently  	subsequently  	 RB	O
discontinued 	discontinued 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
office  	office  	 NN	B-NP
blood  	blood  	 NN	I-NP
pressure  	pressure  	 NN	I-NP
values  	values  	 NNS	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
24-month  	24-month  	 JJ	O
follow-up  	follow-up  	 NN	O
were  	were  	 VBD	O
131±15 	131±15 	 FW	O
/ 	/ 	 FW	O
87±9  	87±9  	 FW	O
mm  	mm  	 FW	B-NP
Hg  	Hg  	 FW	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.0001 	.0001 	 NNP	O
,  	,  	 ,	O
for  	for  	 IN	O
both  	both  	 DT	O
comparisons 	comparisons 	 NNS	O
) 	) 	 -RRB-	O
;  	;  	 :	O
the  	the  	 DT	O
corresponding  	corresponding  	 JJ	O
ABPM  	ABPM  	 NN	B-NP
values  	values  	 NNS	I-NP
were  	were  	 VBD	O
132±14 	132±14 	 FW	O
/ 	/ 	 FW	O
84±12  	84±12  	 FW	O
mm  	mm  	 FW	B-NP
Hg  	Hg  	 FW	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.0001 	.0001 	 NNP	O
,  	,  	 ,	O
for  	for  	 IN	O
both  	both  	 DT	O
comparisons 	comparisons 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 VBP	O
estimated  	estimated  	 VBN	O
glomerular  	glomerular  	 JJ	B-NP
filtration  	filtration  	 JJ	I-NP
rate  	rate  	 NN	I-NP
increased  	increased  	 VBN	O
from  	from  	 IN	O
61.9±23.9  	61.9±23.9  	 FW	O
mL 	mL 	 FW	B-NP
/ 	/ 	 FW	I-NP
min 	min 	 FW	I-NP
/ 	/ 	 FW	O
1.73  	1.73  	 FW	O
m 	m 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
)  	)  	 -RRB-	I-NP
to  	to  	 TO	O
88.0±39.8  	88.0±39.8  	 FW	O
mL 	mL 	 FW	B-NP
/ 	/ 	 FW	I-NP
min 	min 	 FW	I-NP
/ 	/ 	 FW	O
1.73  	1.73  	 FW	O
m 	m 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
)  	)  	 -RRB-	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
.0001 	.0001 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
urine  	urine  	 JJ	B-NP
albumin 	albumin 	 NN	I-NP
: 	: 	 :	O
creatinine  	creatinine  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
decreased  	decreased  	 VBD	O
from  	from  	 IN	O
99.8  	99.8  	 CD	O
mg 	mg 	 CD	B-NP
/ 	/ 	 CD	I-NP
g  	g  	 NNS	I-NP
( 	( 	 -LRB-	O
interquartile  	interquartile  	 JJ	B-NP
range 	range 	 NN	I-NP
,  	,  	 ,	O
38.0-192.1 	38.0-192.1 	 CD	O
)  	)  	 -RRB-	O
to  	to  	 TO	O
11.0  	11.0  	 CD	O
mg 	mg 	 CD	B-NP
/ 	/ 	 CD	I-NP
g  	g  	 NNS	I-NP
( 	( 	 -LRB-	O
interquartile  	interquartile  	 JJ	B-NP
range 	range 	 NN	I-NP
,  	,  	 ,	O
4.1-28.1 	4.1-28.1 	 NNP	O
;  	;  	 :	O
P  	P  	 FW	O
< 	< 	 SYM	O
.0001  	.0001  	 FW	O
mg 	mg 	 FW	B-NP
/ 	/ 	 FW	I-NP
g 	g 	 FW	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
At  	At  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
follow-up  	follow-up  	 JJ	B-NP
period 	period 	 NN	I-NP
,  	,  	 ,	O
21  	21  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
70 	70 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
initial  	initial  	 JJ	O
sample 	sample 	 NN	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
no  	no  	 RB	O
longer  	longer  	 RB	O
classified  	classified  	 VBN	O
as  	as  	 IN	O
having  	having  	 VBG	B-NP
CKD 	CKD 	 NNP	I-NP
.  	.  	 .	O
